Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's disease have taken an hit. A new study found ...

The legendary rocker is reuniting with original Sabbath guitarist Tony Iommi for the show at Premier League football club Aston Villla's stadium in their home city of Birmingham on July 5.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's ...

Black Sabbath have announced the 'final' show by their original lineup, a benefit titled 'Back to the Beginning' with ...

The FDA on Tuesday signed off on Supernus Pharmaceuticals’ apomorphine hydrochloride injection—to be marketed under the brand ...

The original members of Black Sabbath will reunite for a final concert in Birmingham, England. Taking place on July 5, this highly anticipated event will feature iconic members such as Ozzy Osbourne.

Anthony Quinn, 49 and from Pity Me, has now been given a groundbreaking new treatment called Produodopa. Anthony becomes one of the first people in England to receive this outside of specialist ...

Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U.K.. Osbourne, 76, has been ...

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The ...